Earnings Feed
Start Free
BIOMARIN PHARMACEUTICAL INC·4

May 13, 3:57 PM ET

BIENAIME JEAN JACQUES 4

4 · BIOMARIN PHARMACEUTICAL INC · Filed May 13, 2024

Insider Transaction Report

Form 4
Period: 2024-05-09
BIOMARIN PHARMACEUTICAL INCBMRN
BIENAIME JEAN JACQUES
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-05-09$63.10/sh+20,000$1,262,000→ 494,994 total
  • Sale

    Common Stock

    2024-05-09$81.62/sh−20,000$1,632,400→ 474,994 total
  • Exercise/Conversion

    Stock Option (Right to Buy Common Stock)

    2024-05-09−20,000→ 71,000 total
    Exercise: $63.10From: 2014-12-04Exp: 2024-06-03→ Common Stock (20,000 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy Common Stock)

    2024-05-10−20,000→ 51,000 total
    Exercise: $63.10From: 2014-12-04Exp: 2024-06-03→ Common Stock (20,000 underlying)
  • Exercise/Conversion

    Common Stock

    2024-05-10$63.10/sh+20,000$1,262,000→ 494,994 total
  • Sale

    Common Stock

    2024-05-10$81.14/sh−20,000$1,622,800→ 474,994 total
Holdings

  • Common Stock

    (indirect: By Trust)
    247,333

  • Common Stock

    (indirect: By Children)
    100

  • Common Stock

    (indirect: By Children)
    100
Footnotes (2)
  • [F1]Trade made pursuant to a 10b5-1 plan executed on August 7, 2023.
  • [F2]Reflects the number of options outstanding after the transactions from this specific stock option grant.

Documents

1 file
  • 4
    wk-form4_1715630235.xmlPrimary

    FORM 4